Skip to content

Project Baseline Health Study

Project Baseline Health Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03154346
Enrollment
10000
Registered
2017-05-16
Start date
2017-03-29
Completion date
2024-12-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All

Keywords

Baseline, Project Baseline, Baseline Study, Project Baseline Study, Health Study, Baseline Health Study

Brief summary

This study is the first initiative of Project Baseline, a broader effort designed to develop a well-defined reference, or baseline, of good health as well as a rich data platform that may be used to better understand the transition from health to disease and identify additional risk factors for disease. Project Baseline endeavors to test and develop new tools and technologies to collect, organize, and activate health information.

Interventions

None listed

Sponsors

Verily Life Sciences LLC
CollaboratorINDUSTRY
Duke University
CollaboratorOTHER
Stanford University
CollaboratorOTHER
Google LLC.
CollaboratorINDUSTRY
Baseline Study LLC
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 * U.S. Resident * Able to speak and read English * Willing and able to comply with all aspects of the protocol

Exclusion criteria

* Individuals working on Project Baseline, including the Baseline Study * Known severe allergy to nickel or metal jewelry

Design outcomes

Primary

MeasureTime frame
Develop a set of scalable and standardized tools for acquiring, organizing, and analyzing clinical, molecular, imaging, sensor, self-reported, behavioral, environmental, and other health-related measurementsFor the duration of the study
Evaluate the use of sensor technologies for the collection of continuous, accurate health informationFor the duration of the study
Create a dataset encompassing a wide spectrum of phenotypic measures for future exploratory analysisFor the duration of the study
Measure the phenotypic diversity observed among a participant population, defining a range of expected values for multiple types of dataFor the duration of the study
Identify biomarkers of disease-related transitions, including those related to cardiovascular disease and cancerFor the duration of the study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026